A Novel High-Through-Put Assay for Screening of Pro-Apoptotic Drugs (original) (raw)

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Twentyman PR, Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56:279–285, 1987
    Google Scholar
  2. Larsson R, Nygren P: Pharmacological modification of multidrug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells. Int J Cancer 46:67–72, 1990
    Google Scholar
  3. Viktorsson K, Heiden T, Molin M, Akusjärvi G, Linder S, Shoshan MC: Increased apoptosis and increased clonogenic survival of 12V-RAS transformed rat fibroblasts in response to cisplatin. Apoptosis 5:355–367, 2000
    Google Scholar
  4. Kaufmann SH, Earnshaw WC: Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256:42–49, 2000
    Google Scholar
  5. Costantini P, Jacotot E, Decaudin D, Kroemer G: Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst 92:1042–1053, 2000
    Google Scholar
  6. Caulin C, Salvesen GS, Oshima RG: Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 138:1379–1394, 1997
    Google Scholar
  7. Ku NO, Liao J, Omary MB: Apoptosis generates stable fragments of human type I keratins. J Biol Chem 272:33197–33203, 1997
    Google Scholar
  8. MacFarlane M, Merrison W, Dinsdale D, Cohen GM: Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J Cell Biol 148:1239–1254, 2000
    Google Scholar
  9. Leers_MP, Björklund V, Bergman T, Tribbick G, Persson B, Björklund P, Ramaekers FC, Björklund B, Nap MHJ, Schutte B: Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187:567–572, 1999
    Google Scholar
  10. Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S: Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci USA 88:10657–10661, 1991
    Google Scholar
  11. Zhou J-N, Linder S: Expression of CDK inhibitor genes in immortalized and carcinoma derived breast cell lines. Anticancer Res 16:1931–1936, 1996
    Google Scholar
  12. Vanhamme L, Szpirer C: Transforming activity of the human mammary line HBL100 DNA is associated with SV40 large T antigen genetic information integrated in its genome. Carcinogenesis 9:653–655, 1988
    Google Scholar
  13. Rydlander L, Ziegler E, Bergman T, Schoberl E, Steiner G, Bergman AC, Zetterberg A, Marberger M, Bjorklund P, Skern T, Einarsson R, Jornvall H: Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin Eur J Biochem 241:309–314, 1996
    Google Scholar
  14. Janicke RU, Sprengart ML, Wati MR, Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357–9360, 1998
    Google Scholar
  15. Ross WE, Bradley MO: DNA double-stranded breaks in mammalian cells after exposure to intercalating agents. Biochim Biophys Acta 654:129–134, 1981
    Google Scholar
  16. Tewey KM, Chen GL, Nelson EM, Liu LF: Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259:9182–9187, 1984
    Google Scholar
  17. Ohashi M, Sugikawa E, Nakanishi N: Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism. Jpn J Cancer Res 86:819–827, 1995
    Google Scholar

Download references